Lunai Bioworks Inc. current report, 07 November 2013

Business Context and Reporting Period

This Form 8-K was filed by Putnam Hills Corp. (not Lunai Bioworks Inc.) on November 14, 2013, reporting an event that occurred on November 7, 2013. The Company is a Delaware corporation headquartered in Great Neck, NY.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a proposed corporate transaction rather than financial performance.

Material Changes and Transaction Details

On November 7, 2013, Putnam Hills Corp. entered into a non-binding letter of intent (LOI) with Dandrit Biotech A/S, a Danish company. The proposed transaction includes:

  • Acquisition: Putnam Hills agrees to acquire no less than 90% of Dandrit's equity interests.
  • Consideration: Approximately 6,000,000 shares of Putnam Hills common stock to be issued to Dandrit equity holders.
  • Share Cancellation: The existing sole shareholder of Putnam Hills agreed to cancel 4,400,000 shares of common stock as an inducement for the transaction.
  • Management Change: Upon closing, the current sole executive officer and director of Putnam Hills will resign without payment, and Dandrit's executive officers and directors will assume those roles.

Guidance, Outlook, and Risks

The transaction is contingent upon the negotiation and execution of a Definitive Agreement. Key conditions and risks include:

  • Approval Requirement: The Definitive Agreement requires the approval and consent of holders of no less than 90% of Dandrit's issued and outstanding equity interests.
  • Non-Binding Nature: The current LOI is non-binding, meaning the transaction is not guaranteed to close.
  • Regulatory Compliance: The share exchange is subject to compliance with Rule 14f-1 of the Securities Act of 1933.

Investor Verification Checklist

  • Verify the execution of the Definitive Agreement between Putnam Hills Corp. and Dandrit Biotech A/S.
  • Confirm whether the required 90% shareholder approval from Dandrit has been obtained.
  • Monitor the resignation of current Putnam Hills management and the appointment of Dandrit's leadership.
  • Check for the actual cancellation of the 4,400,000 shares by the existing sole shareholder.
  • Review subsequent filings for any updates on the status of the proposed merger.